Collagen Matrix to participate in the FDA’s Experiential Learning Program: 4 points

Collagen Matrix will participate in the FDA’s Experiential Learning Program. 

Advertisement

Here are four points:

 

1. The program is designed to provide the review staff of the FDA’s Center for Devices and Radiological Health with real-world experience in the design, manufacture and use of medical devices.

 

2. Collagen Matrix’s site visit proposal was selected for this year’s ELP training, which will take place at the company’s headquarters in Oakland, N.J.

 

3. Collagen Matrix is the manufacturer and supplier of collagen membranes and bone graft materials.

 

4. Founded in 1997, Collagen Matrix has sales of over 55 medical devices in more than 80 countries worldwide today.

 

More articles on devices:
Xtant Medical reports 6.5% revenue increase, $5.4M net loss: 5 things to know
18 spine devices receive FDA 510(k) clearance in October
Studies reveal the constraints of steroid injections & promise of ozone gas in treating knee arthritis

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.